arrow
J

Jing Zhou

Amgen
H指数:30
被引数:3,257

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A human CD137xPD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade

人CD137xPD-L1双特异性抗体通过上下文依赖性T细胞共刺激和检查点阻断促进抗肿瘤免疫

2021-07-2174
OAAI
MCLA-145 IS A BISPECIFIC IGG1 ANTIBODY THAT INHIBITS PD-1/PD-L1 SIGNALING WHILE SIMULTANEOUSLY ACTIVATING CD137 SIGNALING ON T CELLS
2020-11-090
OAAI
The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents

MDM2抑制剂AMG 232显示出强大的抗肿瘤功效,并增强了p53-Inducing细胞毒性剂的活性

2015-03-09125
OAAI
Discovery of AM-7209, a Potent and Selective 4-Amidobenzoic Acid Inhibitor of the MDM2-p53 Interaction
2014-12-0463
PREAI
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 Interaction
2014-07-0924
OAAI
Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres
2014-03-2761
PREAI